vs
Atai Beckley N.V.（ATAI）与Arcadia Biosciences, Inc.（RKDA）财务数据对比。点击上方公司名可切换其他公司
Arcadia Biosciences, Inc.的季度营收约是Atai Beckley N.V.的1.2倍（$901.0K vs $749.0K），Arcadia Biosciences, Inc.净利率更高（-148.3% vs -8154.1%，领先8005.8%），Atai Beckley N.V.同比增速更快（1772.5% vs -25.8%），过去两年Atai Beckley N.V.的营收复合增速更高（545.1% vs -4.5%）
阿泰生命科学是一家制药企业，专注于研发致幻剂、其他迷幻物质、共情原以及相关药物，用于治疗精神类疾病。该公司成立于2018年，总部位于德国柏林。
阿卡迪亚生物科学是一家美国上市农业生物技术企业，总部位于加利福尼亚州戴维斯，专注于开发可提升作物品质与产量的作物性状改良技术，该公司部分股权归道德指南针公司所有。
ATAI vs RKDA — 直观对比
营收规模更大
RKDA
是对方的1.2倍
$749.0K
营收增速更快
ATAI
高出1798.3%
-25.8%
净利率更高
RKDA
高出8005.8%
-8154.1%
两年增速更快
ATAI
近两年复合增速
-4.5%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $749.0K | $901.0K |
| 净利润 | $-61.1M | $-1.3M |
| 毛利率 | — | 21.4% |
| 营业利润率 | -3796.5% | -152.8% |
| 净利率 | -8154.1% | -148.3% |
| 营收同比 | 1772.5% | -25.8% |
| 净利润同比 | -132.3% | 67.1% |
| 每股收益（稀释后） | $-0.28 | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATAIRKDA
| Q4 25 | — | $901.0K | ||
| Q3 25 | $749.0K | $1.3M | ||
| Q2 25 | $719.0K | $1.5M | ||
| Q1 25 | $1.6M | $1.2M | ||
| Q4 24 | $-5.0K | $1.2M | ||
| Q3 24 | $40.0K | $1.5M | ||
| Q2 24 | $273.0K | $1.3M | ||
| Q1 24 | $0 | $987.0K |
净利润ATAIRKDA
| Q4 25 | — | $-1.3M | ||
| Q3 25 | $-61.1M | $856.0K | ||
| Q2 25 | $-27.7M | $-4.5M | ||
| Q1 25 | $-26.4M | $2.6M | ||
| Q4 24 | $-39.0M | $-4.1M | ||
| Q3 24 | $-26.3M | $-1.6M | ||
| Q2 24 | $-57.3M | $1.1M | ||
| Q1 24 | $-26.7M | $-2.4M |
毛利率ATAIRKDA
| Q4 25 | — | 21.4% | ||
| Q3 25 | — | 32.1% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 31.9% | ||
| Q3 24 | — | 32.9% | ||
| Q2 24 | — | 51.5% | ||
| Q1 24 | — | 52.3% |
营业利润率ATAIRKDA
| Q4 25 | — | -152.8% | ||
| Q3 25 | -3796.5% | -88.5% | ||
| Q2 25 | -3515.0% | -34.4% | ||
| Q1 25 | -1310.0% | 44.2% | ||
| Q4 24 | 605500.0% | -187.7% | ||
| Q3 24 | -56505.0% | -114.5% | ||
| Q2 24 | -9424.5% | — | ||
| Q1 24 | — | -160.9% |
净利率ATAIRKDA
| Q4 25 | — | -148.3% | ||
| Q3 25 | -8154.1% | 65.7% | ||
| Q2 25 | -3856.6% | -306.4% | ||
| Q1 25 | -1699.7% | 216.6% | ||
| Q4 24 | 779160.0% | -334.5% | ||
| Q3 24 | -65715.0% | -104.9% | ||
| Q2 24 | -20993.4% | 81.2% | ||
| Q1 24 | — | -245.5% |
每股收益（稀释后）ATAIRKDA
| Q4 25 | — | $-0.97 | ||
| Q3 25 | $-0.28 | $0.62 | ||
| Q2 25 | $-0.14 | $-3.26 | ||
| Q1 25 | $-0.15 | $1.90 | ||
| Q4 24 | $-0.24 | $-2.99 | ||
| Q3 24 | $-0.16 | $-1.18 | ||
| Q2 24 | $-0.36 | $0.78 | ||
| Q1 24 | $-0.17 | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $30.4M | $4.6M |
| 总债务越低越好 | $0 | — |
| 股东权益账面价值 | $159.8M | $4.1M |
| 总资产 | $239.8M | $6.5M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资ATAIRKDA
| Q4 25 | — | $4.6M | ||
| Q3 25 | $30.4M | $5.9M | ||
| Q2 25 | $61.9M | $4.4M | ||
| Q1 25 | $48.3M | $3.2M | ||
| Q4 24 | $17.5M | $4.2M | ||
| Q3 24 | $30.0M | $6.6M | ||
| Q2 24 | $19.3M | $8.1M | ||
| Q1 24 | $18.9M | $8.5M |
总债务ATAIRKDA
| Q4 25 | — | — | ||
| Q3 25 | $0 | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | $9.3M | — | ||
| Q4 24 | $14.1M | — | ||
| Q3 24 | $20.3M | — | ||
| Q2 24 | $15.2M | — | ||
| Q1 24 | $15.1M | — |
股东权益ATAIRKDA
| Q4 25 | — | $4.1M | ||
| Q3 25 | $159.8M | $5.4M | ||
| Q2 25 | $143.7M | $4.5M | ||
| Q1 25 | $152.1M | $8.9M | ||
| Q4 24 | $116.3M | $6.2M | ||
| Q3 24 | $145.7M | $10.3M | ||
| Q2 24 | $167.9M | $11.7M | ||
| Q1 24 | $222.5M | $10.6M |
总资产ATAIRKDA
| Q4 25 | — | $6.5M | ||
| Q3 25 | $239.8M | $8.6M | ||
| Q2 25 | $189.2M | $7.8M | ||
| Q1 25 | $195.8M | $13.0M | ||
| Q4 24 | $159.4M | $13.5M | ||
| Q3 24 | $197.5M | $15.2M | ||
| Q2 24 | $215.8M | $17.4M | ||
| Q1 24 | $269.1M | $16.0M |
负债/权益比ATAIRKDA
| Q4 25 | — | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.06× | — | ||
| Q4 24 | 0.12× | — | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.09× | — | ||
| Q1 24 | 0.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-23.3M | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | $-23.7M | — |
| 自由现金流率自由现金流/营收 | -3158.5% | — |
| 资本支出强度资本支出/营收 | 52.9% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-80.3M | — |
8季度趋势，按日历期对齐
经营现金流ATAIRKDA
| Q4 25 | — | $-861.0K | ||
| Q3 25 | $-23.3M | $-257.0K | ||
| Q2 25 | $-14.1M | $-2.0M | ||
| Q1 25 | $-17.8M | $-1.6M | ||
| Q4 24 | $-24.3M | $-2.2M | ||
| Q3 24 | $-19.3M | $-1.8M | ||
| Q2 24 | $-16.2M | $-2.5M | ||
| Q1 24 | $-22.6M | $-3.2M |
自由现金流ATAIRKDA
| Q4 25 | — | — | ||
| Q3 25 | $-23.7M | — | ||
| Q2 25 | $-14.2M | — | ||
| Q1 25 | $-18.1M | — | ||
| Q4 24 | $-24.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-2.5M | ||
| Q1 24 | — | $-3.2M |
自由现金流率ATAIRKDA
| Q4 25 | — | — | ||
| Q3 25 | -3158.5% | — | ||
| Q2 25 | -1977.9% | — | ||
| Q1 25 | -1164.6% | — | ||
| Q4 24 | 486020.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -188.3% | ||
| Q1 24 | — | -326.5% |
资本支出强度ATAIRKDA
| Q4 25 | — | 0.0% | ||
| Q3 25 | 52.9% | 0.0% | ||
| Q2 25 | 17.7% | 0.0% | ||
| Q1 25 | 17.2% | 0.0% | ||
| Q4 24 | -120.0% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.2% | ||
| Q1 24 | — | 1.3% |
现金转化率ATAIRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
